Publicaciones (85) Publicaciones de Younes Smani

2024

  1. Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP

    Drug Resistance Updates

2023

  1. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections

    Current Medicinal Chemistry, Vol. 30, Núm. 1, pp. 59-71

  2. Estudio de interacción patógeno-huésped para el descubrimiento de nuevo sagentes antibacterianos

    Investigaciones DACIU 2022-2023: Una publicación que refleja los trabajos realizados por los participantes en el programa DACIU en su primera edición (Avanza), pp. 42-47

  3. In Vitro and In Vivo Virulence Study of Listeria monocytogenes Isolated from the Andalusian Outbreak in 2019

    Tropical Medicine and Infectious Disease, Vol. 8, Núm. 1

  4. In vitro and in vivo evaluation of two combined β-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 11, pp. 1317-1325

  5. Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

    Journal of Infection, Vol. 87, Núm. 3, pp. 220-229

2022

  1. Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections (Front. Microbiol., (2019), 10, (41), 10.3389/fmicb.2019.00041)

    Frontiers in Microbiology

  2. Editorial: Drug re-purposing for the treatment of bacterial infections

    Frontiers in Pharmacology

  3. Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 1, pp. 14-21

  4. Repurposing of the tamoxifen metabolites in combination with tigecycline against Gram-negative bacteria.

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 11

  5. Tissue engineered in-vitro vascular patch fabrication using hybrid 3D printing and electrospinning

    Materials Today Bio, Vol. 14, pp. 100252

  6. Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test

    Emerging Microbes and Infections, Vol. 11, Núm. 1, pp. 2034-2044

  7. iTRAQ-Based Quantitative Proteomic Analysis of Acinetobacter baumannii under Hypoxia and Normoxia Reveals the Role of OmpW as a Virulence Factor

    Microbiology Spectrum, Vol. 10, Núm. 2, pp. 11 p.

2021

  1. AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections

    Frontiers in Microbiology, Vol. 12

  2. Editorial: Antivirulence Drugs Against Bacterial Infections

    Frontiers in Microbiology

  3. Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against acinetobacter baumannii in murine severe infections models

    Antibiotics, Vol. 10, Núm. 2, pp. 1-8

  4. Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections

    Frontiers in Medicine, Vol. 8

  5. Potential tamoxifen repurposing to combat infections by multidrug-resistant gram-negative Bacilli

    Pharmaceuticals, Vol. 14, Núm. 6

  6. Repurposing of the tamoxifen metabolites to combat infections by multidrug-resistant gram-negative bacilli

    Antibiotics, Vol. 10, Núm. 3

  7. Repurposing of the tamoxifen metabolites to treat methicillin-resistant staphylococcus epidermidis and vancomycin-resistant enterococcus faecalis infections

    Microbiology Spectrum, Vol. 9, Núm. 2